4 months Recursion Pharmaceuticals (NASDAQ:RXRX) Trading Down 1.6% Following Insider Selling MarketBeat
Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Down 1.6% Following Insider Selling
XRecursion Pharmaceuticals (NASDAQ:RXRX) Shares Down 1.6% Following Insider Selling
X